http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021353709-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50eb752940fa4aa36756a6bc9f6f3504
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07
filingDate 2021-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad4f3bddf6191e547d815d18b7c9f3d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6286dc85c81c6e8c9c75b2404225f87
publicationDate 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021353709-A1
titleOfInvention Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) Variants And Uses Thereof
abstract Methods of treating obesity and methods of identifying susceptibility of an obese subject to treatment with an agonist of the leptin-melanocortin signaling pathway are provided herein.
priorityDate 2020-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018311309-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16161315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873

Total number of triples: 55.